Shattuck Labs, Inc. (STTK) vs Zevra Therapeutics, Inc. (ZVRA)
Shattuck Labs, Inc. and Zevra Therapeutics, Inc. are both Biotechnology companies. Shattuck Labs, Inc. and Zevra Therapeutics, Inc. are of similar size ($668.7M and $633.3M). Shattuck Labs, Inc. has negative trailing earnings, so its P/E is not meaningful; Zevra Therapeutics, Inc. trades at 11.6×. Zevra Therapeutics, Inc. grew revenue faster over the last twelve months: 119.4% against 106.5%. Zevra Therapeutics, Inc. has the higher net margin (42.3% vs 0.00%) and the higher return on invested capital (0.00% vs −1,230.7%). Across the 17 metrics below, Zevra Therapeutics, Inc. leads on 14 and Shattuck Labs, Inc. on 3.
Valuation
Profitability
| Metric | STTK | ZVRA | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 95.46% | 65.16% |
| Operating margin | 0.00% | 60.54% | 0.00% |
| Net margin | 0.00% | 42.25% | 0.00% |
| Free cash flow margin | 0.00% | 24.30% | 0.00% |
| Return on equity | (39.21%) | 34.33% | (57.72%) |
| Return on assets | (36.88%) | 20.57% | (49.22%) |
| Return on invested capital | (1,230.74%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack